Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

FDA clears IND for lisaftoclax for ER-positive breast cancer and other solid tumors

June 15, 2021

G1 Therapeutics initiates phase II trial of Cosela in metastatic bladder cancer

June 15, 2021

Exelixis and Bristol Myers Squibb agree to study XL-092 with immuno-oncology therapies

June 15, 2021

YL-13027 demonstrates safety and preliminary activity in patients with solid tumors

June 15, 2021

Senda Biosciences identifies new AhR antagonists

June 15, 2021

Suven Life Sciences patents prodrugs of abiraterone for cancer

June 15, 2021

Janssen Pharmaceutica discloses new Mcl-1 inhibitors

June 15, 2021

First patient dosed in phase I/II study of CFT-7455 in hematologic malignancies

June 15, 2021

FDA lifts partial clinical hold on phase II studies of ALX-148 in HNSCC

June 14, 2021

First-in-human study of Carna's CDC7 inhibitor AS-0141 begins dosing

June 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...